{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:47:44Z","timestamp":1792136864553,"version":"4.4.0"},"reference-count":155,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neurourology and Urodynamics"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lower urinary tract dysfunctions (LUTDs) are prevalent among patients with multiple sclerosis (MS), which is the most common immune\u2010mediated neurologic disease among the juvenile population. This study aims to evaluate the efficacy and safety of different methods in the management of MS\u2010related LUTD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta\u2010Analyses (PRISMA) statement and Joanna Briggs Institute (JBI) methods. Systematic review studies that reported the efficacy of any management method for LUTD in MS are considered for inclusion. A systematic search was conducted in PubMed, Scopus, Embase, and Web of Science and risk of bias was assessed using the JBI critical appraisal checklist for systematic reviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 342 screened records, 34 systematic reviews were included. Preliminary efficacy and safety of pelvic floor muscle training (PFMT) and tibial nerve stimulation (TNS), as well as the potential of alpha\u2010blockers, cannabinoids, mirabegron, spinal cord stimulation, sacral neuromodulation, transcranial neuromodulations, vaginal\/rectal and clitoral\/penile stimulation, foot reflexology, craniosacral therapy, and stem cell therapy were suggested. Despite the appropriate efficacy, anticholinergics, desmopressin, intradetrusor injections of botulinum toxin A, vanilloids, and catheterization were found to cause considerable side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Despite a high prevalence of LUTDs in MS patients, evidence basis of the management methods is still poor and there is lack of well\u2010designed randomized controlled trials, which makes evidence inconclusive. Future research is needed to refine treatment algorithms, investigate the potential of combination therapies, and develop individualized treatment paradigms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/nau.70492","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:03:39Z","timestamp":1792134219000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Urinary Symptoms in Multiple Sclerosis: An Umbrella Review"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-4885","authenticated-orcid":false,"given":"Sina","family":"Hamzehzadeh","sequence":"first","affiliation":[{"name":"Student Research Committee Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8850-8622","authenticated-orcid":false,"given":"Donyasadat","family":"Hashemian","sequence":"additional","affiliation":[{"name":"Student Research Committee Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7946-6618","authenticated-orcid":false,"given":"Saman","family":"Baharomid","sequence":"additional","affiliation":[{"name":"Student Research Committee Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0652-7693","authenticated-orcid":false,"given":"Fateme","family":"Tahmasebi","sequence":"additional","affiliation":[{"name":"Research Center for Integrative Medicine in Aging, Aging Research Institute Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0798-0745","authenticated-orcid":false,"given":"Seyedemad","family":"Seyedgholami Sharabiani","sequence":"additional","affiliation":[{"name":"Student Research Committee Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-7097","authenticated-orcid":false,"given":"Sakineh","family":"Hajebrahimi","sequence":"additional","affiliation":[{"name":"Research Center for Evidence\u2010Based Medicine, Iranian EBM Centre: A Joanna Briggs Institute (JBI) Center of Excellence Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-3913","authenticated-orcid":false,"given":"Mahnaz","family":"Talebi","sequence":"additional","affiliation":[{"name":"Neurosciences Research Center (NSRC) Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9030-2106","authenticated-orcid":false,"given":"Hanieh","family":"Salehi\u2010Pourmehr","sequence":"additional","affiliation":[{"name":"Research Center for Evidence\u2010Based Medicine, Iranian EBM Centre: A Joanna Briggs Institute (JBI) Center of Excellence Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-0109","authenticated-orcid":false,"given":"Amirreza","family":"Naseri","sequence":"additional","affiliation":[{"name":"Student Research Committee Tabriz University of Medical Sciences Tabriz Iran"},{"name":"Research Center for Integrative Medicine in Aging, Aging Research Institute Tabriz University of Medical Sciences Tabriz Iran"},{"name":"Research Center for Evidence\u2010Based Medicine, Iranian EBM Centre: A Joanna Briggs Institute (JBI) Center of Excellence Tabriz University of Medical Sciences Tabriz Iran"},{"name":"Tabriz USERN Office, Universal Scientific Education and Research Network (USERN) Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"14","key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising Prevalence of Multiple Sclerosis Worldwide: Insights From the Atlas of MS, Third Edition","volume":"26","author":"Walton C.","year":"2020","journal-title":"Multiple Sclerosis Journal"},{"issue":"1","key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s44197-025-00353-6","article-title":"Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub\u2010National\u2010Level Estimates and Future Projections","volume":"15","author":"Khan G.","year":"2025","journal-title":"Journal of Epidemiology and Global Health"},{"key":"e_1_2_11_4_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical Features of Late\u2010Onset Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis","volume":"50","author":"Naseri A.","year":"2021","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"10","key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.3390\/app13105881","article-title":"Why Is Multiple Sclerosis More Frequent in Women? Role of the Immune System and of Oral and Gut Microbiota","volume":"13","author":"D'Anca M.","year":"2023","journal-title":"Applied Sciences"},{"issue":"5","key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrurol.2016.53","article-title":"Management of Neurogenic Bladder in Patients With Multiple Sclerosis","volume":"13","author":"Ph\u00e9 V.","year":"2016","journal-title":"Nature Reviews Urology"},{"issue":"4","key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.juro.2009.12.029","article-title":"Under Treatment of Overactive Bladder Symptoms in Patients With Multiple Sclerosis: An Ancillary Analysis of the NARCOMS Patient Registry","volume":"183","author":"Mahajan S. T.","year":"2010","journal-title":"Journal of Urology"},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","DOI":"10.1177\/20503121231178047","article-title":"Multiple Sclerosis and Lower Urinary Tract Symptoms: A Survey of Prevalence, Characteristic and Urological Evaluations","volume":"11","author":"Sharifiaghdas F.","year":"2023","journal-title":"SAGE Open Medicine"},{"issue":"5","key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/JU.0000000000002235","article-title":"The AUA\/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation","volume":"206","author":"Ginsberg D. A.","year":"2021","journal-title":"Journal of Urology"},{"issue":"1","key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s41983-020-00178-z","article-title":"Bladder and Urodynamic Changes in Multiple Sclerosis","volume":"56","author":"Torad H.","year":"2020","journal-title":"Egyptian Journal of Neurology, Psychiatry and Neurosurgery"},{"issue":"2","key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7224\/1537-2073.2019-030","article-title":"Prevalence of Lower Urinary Tract Symptoms in People With Multiple Sclerosis","volume":"22","author":"Al Dandan H. B.","year":"2020","journal-title":"International Journal of MS Care"},{"issue":"9","key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1007\/s10072-024-07570-0","article-title":"Prevalence of Stress Urinary Incontinence and Urge Urinary Incontinence in Multiples Sclerosis Patients: A Systematic Review and Meta\u2010Analysis","volume":"45","author":"Ghasemi V.","year":"2024","journal-title":"Neurological Sciences"},{"key":"e_1_2_11_13_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104010","article-title":"The Effects of Incontinence on Functionality, Disability, and Quality of Life in Male and Female Patients With Multiple Sclerosis","volume":"66","author":"Abakay H.","year":"2022","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"10","key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.purol.2022.05.003","article-title":"Impact on Quality of Life in Multiple Sclerosis Patients: Which Urinary Symptoms Are to Blame?","volume":"32","author":"Ziadeh T.","year":"2022","journal-title":"Progr\u00e8s en Urologie"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105884","article-title":"Algorithms for the First\u2010Line Management of Bladder, Bowel and Sexual Dysfunction in Multiple Sclerosis: Present and Future","volume":"91","author":"Tota V.","year":"2024","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"2","key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5213\/inj.2040028.014","article-title":"Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies","volume":"24","author":"Bientinesi R.","year":"2020","journal-title":"International Neurourology Journal"},{"issue":"3","key":"e_1_2_11_17_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5489\/cuaj.4059","article-title":"Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: Review of the Literature and Current Guidelines","volume":"11","author":"Aharony S. M.","year":"2017","journal-title":"Canadian Urological Association Journal"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2022.2162223"},{"issue":"8","key":"e_1_2_11_19_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11910-018-0857-z","article-title":"The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis","volume":"18","author":"Tornic J.","year":"2018","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"12","key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/14656566.2020.1767068","article-title":"Pharmacotherapeutic Management of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients","volume":"21","author":"Zangh\u00ec A.","year":"2020","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"17","key":"e_1_2_11_21_1","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1212\/WNL.0000000000000363","article-title":"Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders [RETIRED]: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"82","author":"Koppel B. S.","year":"2014","journal-title":"Neurology"},{"key":"e_1_2_11_22_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.urology.2020.10.024","article-title":"Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review","volume":"148","author":"Taylor C.","year":"2021","journal-title":"Urology"},{"issue":"8","key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/nau.22374","article-title":"Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis: A Systematic Review and Turkish Consensus Report","volume":"32","author":"\u00c7etinel B.","year":"2013","journal-title":"Neurourology and Urodynamics"},{"issue":"5","key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.euf.2020.02.007","article-title":"Nocturia and Nocturnal Polyuria in Neurological Patients: From Epidemiology to Treatment. A Systematic Review of the Literature","volume":"6","author":"Haddad R.","year":"2020","journal-title":"European Urology Focus"},{"issue":"5","key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11934-012-0266-9","article-title":"The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review","volume":"13","author":"Tubaro A.","year":"2012","journal-title":"Current Urology Reports"},{"key":"e_1_2_11_26_1","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page M. J.","year":"2021","journal-title":"BMJ"},{"key":"e_1_2_11_27_1","doi-asserted-by":"crossref","unstructured":"E.AromatarisandZ.Munn eds. JBI Manual for Evidence Synthesis(JBI 2020) https:\/\/synthesismanualjbiglobal https:\/\/doi.org\/10.46658\/JBIMES-20-01.","DOI":"10.46658\/JBIMES-20-01"},{"issue":"1","key":"e_1_2_11_28_1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A Web and Mobile App for Systematic Reviews","volume":"5","author":"Ouzzani M.","year":"2016","journal-title":"Systematic Reviews"},{"issue":"3","key":"e_1_2_11_29_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing Systematic Reviews: Methodological Development, Conduct and Reporting of an Umbrella Review Approach","volume":"13","author":"Aromataris E.","year":"2015","journal-title":"International Journal of Evidence\u2010Based Healthcare"},{"issue":"2","key":"e_1_2_11_30_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11910-018-0814-x","article-title":"The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: A Systematic Review of Reviews","volume":"18","author":"Nielsen S.","year":"2018","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"2","key":"e_1_2_11_31_1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/nau.25343","article-title":"Effects of Posterior Tibial Nerve Stimulation (PTNS) on Lower Urinary Tract Dysfunction: An Umbrella Review","volume":"43","author":"Tahmasbi F.","year":"2024","journal-title":"Neurourology and Urodynamics"},{"issue":"3","key":"e_1_2_11_32_1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ucl.2017.04.012","article-title":"Disease\u2010Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity","volume":"44","author":"Kaviani A.","year":"2017","journal-title":"Urologic Clinics of North America"},{"issue":"4","key":"e_1_2_11_33_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11884-017-0454-z","article-title":"Clinical Factors to Decide Between Sacral Neuromodulation and Onabotulinum Toxin\u2014When Is One Clearly Better?","volume":"12","author":"Nguyen L. N.","year":"2017","journal-title":"Current Bladder Dysfunction Reports"},{"issue":"8","key":"e_1_2_11_34_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11910-018-0859-x","article-title":"Cannabinoids for Treatment of MS Symptoms: State of the Evidence","volume":"18","author":"Rice J.","year":"2017","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"3","key":"e_1_2_11_35_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1442-2042.2011.02946.x","article-title":"Botulinum Toxin Type A for the Treatment of Lower Urinary Tract Disorders","volume":"19","author":"Yokoyama T.","year":"2012","journal-title":"International Journal of Urology"},{"issue":"7","key":"e_1_2_11_36_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sc.2016.192","article-title":"Outcome Comparison of Different Approaches to Self\u2010Intermittent Catheterization in Neurogenic Patients: A Systematic Review","volume":"55","author":"Shamout S.","year":"2017","journal-title":"Spinal Cord"},{"issue":"1","key":"e_1_2_11_37_1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/13696998.2023.2165366","article-title":"Efficacy of AbobotulinumtoxinA Versus OnabotulinumtoxinA for the Treatment of Refractory Neurogenic Detrusor Overactivity: A Systematic Review and Indirect Treatment Comparison","volume":"26","author":"Cruz F.","year":"2023","journal-title":"Journal of Medical Economics"},{"issue":"10","key":"e_1_2_11_38_1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40265-013-0068-5","article-title":"Efficacy and Safety of Botulinum Toxin A Intradetrusor Injections in Adults With Neurogenic Detrusor Overactivity\/Neurogenic Overactive Bladder: A Systematic Review","volume":"73","author":"Soljanik I.","year":"2013","journal-title":"Drugs"},{"issue":"2","key":"e_1_2_11_39_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11255-011-0054-3","article-title":"Efficacy and Safety of Desmopressin for Treatment of Nocturia: A Systematic Review and Meta\u2010Analysis of Double\u2010Blinded Trials","volume":"44","author":"Zong H.","year":"2012","journal-title":"International Urology and Nephrology"},{"issue":"2","key":"e_1_2_11_40_1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/nau.23354","article-title":"Is Repeat Botulinum Toxin A Injection Valuable for Neurogenic Detrusor Overactivity\u2014A Systematic Review and Meta\u2010Analysis","volume":"37","author":"Ni J.","year":"2018","journal-title":"Neurourology and Urodynamics"},{"issue":"5","key":"e_1_2_11_41_1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.euf.2018.02.009","article-title":"Surgical Management of Anatomic Bladder Outlet Obstruction in Males With Neurogenic Bladder Dysfunction: A Systematic Review","volume":"5","author":"Noordhoff T. C.","year":"2019","journal-title":"European Urology Focus"},{"issue":"4","key":"e_1_2_11_42_1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4081\/aiua.2022.4.492","article-title":"Efficacy of Overactive Neurogenic Bladder Treatment: A Systematic Review of Randomized Controlled Trials","volume":"94","author":"Bapir R.","year":"2022","journal-title":"Archivio Italiano di Urologia e Andrologia"},{"issue":"4","key":"e_1_2_11_43_1","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s12325-021-01650-9","article-title":"Systematic Literature Review and Meta\u2010Analysis of Sacral Neuromodulation (SNM) in Patients With Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions","volume":"38","author":"Ophoven A.","year":"2021","journal-title":"Advances in Therapy"},{"issue":"7","key":"e_1_2_11_44_1","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3390\/medicina60071152","article-title":"The Efficiency of Rehabilitation Therapy in Patients Diagnosed With Neurogenic Bladder: A Systematic Review","volume":"60","author":"Manaila A. I.","year":"2024","journal-title":"Medicina"},{"issue":"19","key":"e_1_2_11_45_1","doi-asserted-by":"crossref","first-page":"5846","DOI":"10.3390\/jcm13195846","article-title":"Does Surgical Treatment for Benign Prostate Enlargement (BPE)\u2010Related Bladder Outlet Obstruction (BOO) Benefit Patients With Central Nervous System Diseases? A Systematic Review","volume":"13","author":"Charalampous I.","year":"2024","journal-title":"Journal of Clinical Medicine"},{"issue":"4","key":"e_1_2_11_46_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11884-018-0482-3","article-title":"Contemporary Treatment of Detrusor Sphincter Dyssynergia: A Systematic Review","volume":"13","author":"Li H.","year":"2018","journal-title":"Current Bladder Dysfunction Reports"},{"issue":"1","key":"e_1_2_11_47_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5173\/ceju.2024.0125","article-title":"Role of Gabapentin in the Management of Neurogenic Overactive Bladders: A Systematic Review","volume":"78","author":"Chanchlani R.","year":"2025","journal-title":"Central European Journal of Urology"},{"issue":"2","key":"e_1_2_11_48_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10790268.2008.11760706","article-title":"Neurotoxin Treatments for Urinary Incontinence in Subjects With Spinal Cord Injury or Multiple Sclerosis: A Systematic Review of Effectiveness and Adverse Effects","volume":"31","author":"MacDonald R.","year":"2008","journal-title":"Journal of Spinal Cord Medicine"},{"key":"e_1_2_11_49_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.msard.2018.10.115","article-title":"The Role of Phospholipase A2 in Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis","volume":"27","author":"Trotter A.","year":"2019","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"11","key":"e_1_2_11_50_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s40263-019-00671-x","article-title":"Effects of Fampridine in People With Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis","volume":"33","author":"Valet M.","year":"2019","journal-title":"CNS Drugs"},{"issue":"2","key":"e_1_2_11_51_1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5114\/aoms.2010.13901","article-title":"Original Research A Meta\u2010Analysis on the Efficacy and Tolerability of Natalizumab in Relapsing Multiple Sclerosis","volume":"2","author":"Nikfar S.","year":"2010","journal-title":"Archives of Medical Science"},{"key":"e_1_2_11_52_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106212","article-title":"Coenzyme Q10 Supplementation in Multiple Sclerosis; A Systematic Review","volume":"93","author":"Salekzamani S.","year":"2025","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"10","key":"e_1_2_11_53_1","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1007\/s12011-023-04026-y","article-title":"Shining a Light on Selenium: A Meta\u2010Analysis of Supplementation in Multiple Sclerosis","volume":"202","author":"Rahmani M.","year":"2024","journal-title":"Biological Trace Element Research"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003982.pub2"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.589146"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009130.pub3"},{"issue":"3","key":"e_1_2_11_57_1","article-title":"Rituximab for People With Multiple Sclerosis","volume":"3","author":"Filippini G.","year":"2025","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"e_1_2_11_58_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1756285613512712","article-title":"4\u2010Aminopyridine for Symptomatic Treatment of Multiple Sclerosis: A Systematic Review","volume":"7","author":"Jensen H. B.","year":"2014","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"10","key":"e_1_2_11_59_1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1089\/jicm.2021.0382","article-title":"The Efficacy and Safety of Manual Therapy for Symptoms Associated With Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis","volume":"28","author":"Zhang T.","year":"2022","journal-title":"Journal of Integrative and Complementary Medicine"},{"key":"e_1_2_11_60_1","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9463314","article-title":"Efficacy and Safety of Mesenchymal Stem Cell Transplantation in the Treatment of Autoimmune Diseases (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Multiple Sclerosis, and Ankylosing Spondylitis): A Systematic Review and Meta\u2010Analysis of Randomized Controlled Trial","volume":"2022","author":"Zeng L.","year":"2022","journal-title":"Stem Cells International"},{"issue":"19","key":"e_1_2_11_61_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12196311","article-title":"Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis","volume":"12","author":"Islam M. A.","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"10","key":"e_1_2_11_62_1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neurol.2023.07.017","article-title":"Mediterranean\u2010Like Diets in Multiple Sclerosis: A Systematic Review","volume":"180","author":"Abbasi H.","year":"2024","journal-title":"Revue Neurologique"},{"key":"e_1_2_11_63_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106739","article-title":"Efficacy of the Mediterranean Diet in the Treatment of Multiple Sclerosis (RRMS): A Systematic Review and Meta\u2010Analysis","volume":"104","author":"Kong J.","year":"2025","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"6","key":"e_1_2_11_64_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127960","article-title":"A Network Meta\u2010Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta\u20101a Versus Other Injectable Therapies for the Treatment of Relapsing\u2010Remitting Multiple Sclerosis","volume":"10","author":"Tolley K.","year":"2015","journal-title":"PLoS One"},{"key":"e_1_2_11_65_1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.msard.2018.05.008","article-title":"The Efficacy of Vitamin D in Multiple Sclerosis: A Meta\u2010Analysis","volume":"23","author":"Zheng C.","year":"2018","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"e_1_2_11_66_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110266","article-title":"A Systematic Review of the Safety and Efficacy of Monoclonal Antibodies for Progressive Multiple Sclerosis","volume":"120","author":"Sabahi Z.","year":"2023","journal-title":"International Immunopharmacology"},{"issue":"5","key":"e_1_2_11_67_1","article-title":"Ocrelizumab for Multiple Sclerosis","volume":"5","author":"Lin M.","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_11_68_1","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X241293114","article-title":"The Effects of Coffee\/Caffeine in Patients With Multiple Sclerosis; A Systematic Review","volume":"29","author":"Salekzamani S.","year":"2024","journal-title":"Journal of Evidence\u2010Based Integrative Medicine"},{"issue":"4","key":"e_1_2_11_69_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319755","article-title":"The Potential Effectiveness of Probiotics in Reducing Multiple Sclerosis Progression in Preclinical and Clinical Studies: A Worldwide Systematic Review and Meta\u2010Analysis","volume":"20","author":"Zangeneh Z.","year":"2025","journal-title":"PLoS One"},{"issue":"4","key":"e_1_2_11_70_1","first-page":"222","article-title":"Pelvic Floor Muscles Training, Electrical Stimulation, Bladder Training and Lifestyle Interventions to Manage Lower Urinary Tract Dysfunction in Multiple Sclerosis: A Systematic Review","volume":"24","author":"Gaspard L.","year":"2014","journal-title":"Progr\u00e8s en Urologie"},{"issue":"6","key":"e_1_2_11_71_1","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/nau.24039","article-title":"Alpha\u2010Blockers for Treating Neurogenic Lower Urinary Tract Dysfunction in Patients With Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis. A Report From the Neuro\u2010Urology Promotion Committee of the International Continence Society (ICS)","volume":"38","author":"Schneider M. P.","year":"2019","journal-title":"Neurourology and Urodynamics"},{"issue":"5","key":"e_1_2_11_72_1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2012.02.036","article-title":"Anticholinergic Drugs for Adult Neurogenic Detrusor Overactivity: A Systematic Review and Meta\u2010Analysis","volume":"62","author":"Madhuvrata P.","year":"2012","journal-title":"European Urology"},{"key":"e_1_2_11_73_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106845","article-title":"Antimuscarinics in Multiple Sclerosis: A Systematic Review","volume":"104","author":"Darvishi A.","year":"2025","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"4","key":"e_1_2_11_74_1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bju.13759","article-title":"Cannabinoids for Treating Neurogenic Lower Urinary Tract Dysfunction in Patients With Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis","volume":"119","author":"Abo Youssef N.","year":"2017","journal-title":"BJU International"},{"issue":"6","key":"e_1_2_11_75_1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3485","article-title":"Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis","volume":"1","author":"Torres\u2010Moreno M. C.","year":"2018","journal-title":"JAMA Network Open"},{"issue":"1","key":"e_1_2_11_76_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2005.00431.x","article-title":"Efficacy of Desmopressin in Patients With Multiple Sclerosis Suffering From Bladder Dysfunction: A Meta\u2010Analysis","volume":"112","author":"Bosma R.","year":"2005","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"e_1_2_11_77_1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/nau.23921","article-title":"Desmopressin for Treating Nocturia in Patients With Multiple Sclerosis: A Systematic Review: A Report From the Neuro\u2010Urology Promotion Committee of the International Continence Society (ICS)","volume":"38","author":"Ph\u00e9 V.","year":"2019","journal-title":"Neurourology and Urodynamics"},{"issue":"1","key":"e_1_2_11_78_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.25291","article-title":"Efficacy and Safety of Desmopressin in Nocturia and Nocturnal Polyuria Control of Neurological Patients: A Systematic Review and Meta\u2010Analysis","volume":"43","author":"Hajebrahimi S.","year":"2024","journal-title":"Neurourology and Urodynamics"},{"issue":"10","key":"e_1_2_11_79_1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41393-022-00853-3","article-title":"Efficacy and Safety of Mirabegron for Treatment of Neurogenic Detrusor Overactivity in Adults With Spinal Cord Injury or Multiple Sclerosis: A Systematic Review","volume":"60","author":"Akkoc Y.","year":"2022","journal-title":"Spinal Cord"},{"issue":"5","key":"e_1_2_11_80_1","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s10787-023-01271-4","article-title":"Clinical Efficacy and Safety of Melatonin Supplementation in Multiple Sclerosis: A Systematic Review","volume":"31","author":"Morsali S.","year":"2023","journal-title":"Inflammopharmacology"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.23736\/S1973-9087.22.07217-3"},{"key":"e_1_2_11_82_1","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211063059","article-title":"Effects of Nonsurgical, Minimally or Noninvasive Therapies for Urinary Incontinence Due to Neurogenic Bladder: A Systematic Review and Meta\u2010Analysis","volume":"13","author":"Ali M. U.","year":"2022","journal-title":"Therapeutic Advances in Chronic Disease"},{"key":"e_1_2_11_83_1","article-title":"Cortical, Spinal, Sacral, and Peripheral Neuromodulations as Therapeutic Approaches for the Treatment of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients: A Review","author":"Pericolini M.","year":"2021","journal-title":"Neuromodulation"},{"key":"e_1_2_11_84_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/9969010","article-title":"Is There a Place for Spinal Cord Stimulation in the Management of Patients With Multiple Sclerosis? A Systematic Review of the Literature","volume":"2021","author":"Rapisarda A.","year":"2021","journal-title":"Minimally Invasive Surgery"},{"issue":"6","key":"e_1_2_11_85_1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2010.09.024","article-title":"Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: Systematic Review and Meta\u2010Analysis","volume":"58","author":"Kessler T. M.","year":"2010","journal-title":"European Urology"},{"issue":"3","key":"e_1_2_11_86_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00192-015-2771-0","article-title":"Sacral Neuromodulation: An Effective Treatment for Lower Urinary Tract Symptoms in Multiple Sclerosis","volume":"27","author":"Puccini F.","year":"2016","journal-title":"International Urogynecology Journal"},{"issue":"1","key":"e_1_2_11_87_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/nau.70163","article-title":"Efficacy and Safety of Sacral Neuromodulation on Patients With Multiple Sclerosis and Lower Urinary Tract Dysfunction: A Systematic Review and Meta\u2010Analysis","volume":"45","author":"Ferreira C.","year":"2026","journal-title":"Neurourology and Urodynamics"},{"issue":"11","key":"e_1_2_11_88_1","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.clinph.2019.08.020","article-title":"Transcranial Magnetic Stimulation and Bladder Function: A Systematic Review","volume":"130","author":"Nardone R.","year":"2019","journal-title":"Clinical Neurophysiology"},{"issue":"3","key":"e_1_2_11_89_1","first-page":"199","article-title":"Current Evidence on the Potential Therapeutic Applications of Transcranial Magnetic Stimulation in Multiple Sclerosis: A Systematic Review of the Literature","volume":"37","author":"Ruiz M. L.","year":"2022","journal-title":"Neurolog\u00eda"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.001"},{"key":"e_1_2_11_91_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103392","article-title":"Percutaneous Posterior Tibial Nerve Stimulation (PTNS) for Lower Urinary Tract Symptoms (LUTSs) Treatment in Patients With Multiple Sclerosis (MS): A Systematic Review and Meta\u2010Analysis","volume":"58","author":"Guitynavard F.","year":"2022","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"e_1_2_11_92_1","doi-asserted-by":"crossref","unstructured":"F.Tahmasbi S.Hosseini S.Hajebrahimi R.Heris andH.Salehi\u2010Pourmehr \u201cEfficacy of Tibial Nerve Stimulation in Neurogenic Lower Urinary Tract Dysfunction Among Patients With Multiple Sclerosis: A Systematic Review and Meta\u2010analysis \u201d (2023).","DOI":"10.5152\/tud.2023.22241"},{"issue":"6","key":"e_1_2_11_93_1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.eururo.2016.01.010","article-title":"Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review","volume":"69","author":"Gross T.","year":"2016","journal-title":"European Urology"},{"key":"e_1_2_11_94_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103538","article-title":"Pelvic Floor Muscle Training on Urinary Incontinence and Sexual Function in People With Multiple Sclerosis: A Systematic Review","volume":"58","author":"Yavas I.","year":"2022","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"e_1_2_11_95_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103559","article-title":"Pelvic Floor Muscle Training in Multiple Sclerosis Patients With Lower Urinary Tract Dysfunction: A Systematic Review and Meta\u2010Analysis","volume":"59","author":"Kajbafvala M.","year":"2022","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"2","key":"e_1_2_11_96_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.7224\/1537-2073.2022-093","article-title":"Effect of Foot Reflexology on Patients With Multiple Sclerosis: A Systematic Review of Current Evidence","volume":"26","author":"Deenadayalan B.","year":"2024","journal-title":"International Journal of MS Care"},{"issue":"6","key":"e_1_2_11_97_1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ctim.2012.07.009","article-title":"A Systematic Review to Evaluate the Clinical Benefits of Craniosacral Therapy","volume":"20","author":"J\u00e4kel A.","year":"2012","journal-title":"Complementary Therapies in Medicine"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-021-04986-6"},{"key":"e_1_2_11_99_1","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1361723","article-title":"Mesenchymal Stem Cell\u2010Based Therapies for Treating Well\u2010Studied Neurological Disorders: A Systematic Review","volume":"11","author":"Patel G. D.","year":"2024","journal-title":"Frontiers in Medicine"},{"issue":"5","key":"e_1_2_11_100_1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004927.pub4","article-title":"Surgical Management of Functional Bladder Outlet Obstruction in Adults With Neurogenic Bladder Dysfunction","volume":"2014","author":"Utomo E.","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_11_101_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.urology.2020.03.007","article-title":"Use of Botulinum Toxin A (BoNT\u2010A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta \u2010Analysis","volume":"140","author":"Goel S.","year":"2020","journal-title":"Urology"},{"issue":"4","key":"e_1_2_11_102_1","first-page":"588","article-title":"Onabotulinumtoxin Intra\u2010Detrusor Injection for Lower Urinary Tract Symptoms (LUTS) in Patients With Multiple Sclerosis (MS): A Systematic Review and Meta\u2010Analysis","volume":"16","author":"Soltanzadi A.","year":"2025","journal-title":"Caspian Journal of Internal Medicine"},{"issue":"1","key":"e_1_2_11_103_1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/nau.23314","article-title":"Intravesical Vanilloids for Treating Neurogenic Lower Urinary Tract Dysfunction in Patients With Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis. A Report From the Neuro\u2010Urology Promotion Committee of the International Continence Society (ICS)","volume":"37","author":"Ph\u00e9 V.","year":"2018","journal-title":"Neurourology and Urodynamics"},{"issue":"8","key":"e_1_2_11_104_1","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/nau.23733","article-title":"Catheterization for Treating Neurogenic Lower Urinary Tract Dysfunction in Patients With Multiple Sclerosis: A Systematic Review. A Report From the Neuro\u2010Urology Promotion Committee of the International Continence Society (ICS)","volume":"37","author":"Tornic J.","year":"2018","journal-title":"Neurourology and Urodynamics"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30277-5"},{"key":"e_1_2_11_106_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106028","article-title":"67. Domain\u2010Specific and Global Cognitive Impairment in Multiple Sclerosis Patients Based on Cambridge Neuropsychological Test Automated Battery","volume":"92","author":"Sahebari S. S.","year":"2024","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"e_1_2_11_107_1","article-title":"The Prevalence of Cognitive Impairment in Relapsing\u2010Remitting Multiple Sclerosis: A Systematic Review and Meta\u2010Analysis","author":"Wu W.","year":"2024","journal-title":"Neuropsychology Review"},{"key":"e_1_2_11_108_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharmthera.2018.04.010","article-title":"Basic and Clinical Aspects of Antimuscarinic Agents Used to Treat Overactive Bladder","volume":"189","author":"Yamada S.","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"issue":"6","key":"e_1_2_11_109_1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.21037\/tau-24-4","article-title":"Risk Factors for Hyponatremia Associated With Desmopressin Use","volume":"13","author":"Kim J. H.","year":"2024","journal-title":"Translational Andrology and Urology"},{"key":"e_1_2_11_110_1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1379538","article-title":"Managing Multiple Sclerosis in Individuals Aged 55 and Above: A Comprehensive Review","volume":"15","author":"Fern\u00e1ndez \u00d3.","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"e_1_2_11_111_1","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.72192","article-title":"Case Report of Acute Severe Hyponatremia Induced by Desmopressin Administration During Chemotherapy","volume":"14","author":"Ono K.","year":"2026","journal-title":"Clinical Case Reports"},{"issue":"4","key":"e_1_2_11_112_1","first-page":"498","article-title":"Desmopressin Treatment for Nocturia Caused by Nocturnal Polyuria: Practical Guidelines","volume":"73","author":"Przydacz M.","year":"2020","journal-title":"Central European Journal of Urology"},{"issue":"4","key":"e_1_2_11_113_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/nau.25439","article-title":"An Individual Participant Meta\u2010Analysis of Mirabegron in Multiple Sclerosis and Spinal Cord Injury","volume":"43","author":"Welk B.","year":"2024","journal-title":"Neurourology and Urodynamics"},{"issue":"1","key":"e_1_2_11_114_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-78492-2","article-title":"Efficacy of the Combination of Transcutaneous Tibial Nerve Stimulation and Mirabegron in Women With Overactive Bladder in a Prospective Randomized Controlled Trial","volume":"14","author":"Xu Y. X.","year":"2024","journal-title":"Scientific Reports"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.121608"},{"key":"e_1_2_11_116_1","doi-asserted-by":"crossref","DOI":"10.1590\/1980-5764-dn-2022-0053","article-title":"Cognitive Effects of Individual Anticholinergic Drugs: A Systematic Review and Meta\u2010Analysis","volume":"17","author":"Naseri A.","year":"2023","journal-title":"Dementia & Neuropsychologia"},{"key":"e_1_2_11_117_1","article-title":"The Efficacy of Antimuscarinics Agents in Patients With Multiple Sclerosis With Lower Urinary Tract Symptoms (LUTS) (PP\u201037)","volume":"3","author":"Alipour A.","year":"2024","journal-title":"Neurology Letters"},{"issue":"4","key":"e_1_2_11_118_1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.msard.2012.05.002","article-title":"Cognitive Impact of Anticholinergic Medication in MS: Adding Insult to Injury?","volume":"1","author":"Cruce R.","year":"2012","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"e_1_2_11_119_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.urology.2023.11.033","article-title":"Oxybutynin\u2010Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment","volume":"186","author":"Chancellor M. B.","year":"2024","journal-title":"Urology"},{"key":"e_1_2_11_120_1","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2021e11721","article-title":"Treatment of Bladder Dysfunction With Solifenacin: Is There a Risk of Dementia or Cognitive Impairment?","volume":"55","author":"Dantas L. P.","year":"2022","journal-title":"Brazilian Journal of Medical and Biological Research"},{"issue":"10","key":"e_1_2_11_121_1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/14740338.2024.2392000","article-title":"An Update on the Cognitive Safety of Antimuscarinics in the Treatment of Overactive Bladder","volume":"23","author":"Alghamdi M. M.","year":"2024","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"e_1_2_11_122_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.18553\/jmcp.2018.24.1.65","article-title":"Comparative Effectiveness of Anticholinergic Agents for Lower Urinary Tract Symptoms","volume":"24","author":"Goodson A. B.","year":"2018","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"key":"e_1_2_11_123_1","article-title":"UP\u201001.88: Darifenacin Is Also Effective in Neurogenic Bladder Dysfunction (Multiple Sclerosis)","volume":"68","author":"Carl S.","year":"2006","journal-title":"Urology"},{"issue":"4","key":"e_1_2_11_124_1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/WNF.0000000000000596","article-title":"Efficacy and Safety of Mirabegron Add\u2010On Therapy After Failure With Solifenacin in Multiple Sclerosis Patients With Overactive Bladder: A Pilot Study","volume":"47","author":"Mut S. E.","year":"2024","journal-title":"Clinical Neuropharmacology"},{"key":"e_1_2_11_125_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104252","article-title":"Posterior Tibial Nerve Stimulation as a Neuromodulation Therapy in Treatment of Neurogenic Overactive Bladder in Multiple Sclerosis: A Prospective Randomized Controlled Study","volume":"68","author":"Marzouk M. H.","year":"2022","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"1","key":"e_1_2_11_126_1","doi-asserted-by":"crossref","DOI":"10.1186\/s40814-022-01120-1","article-title":"Feasibility and Acceptability of Transcutaneous Tibial Nerve Stimulation for the Treatment of Bladder Storage Symptoms Among People With Multiple Sclerosis","volume":"8","author":"Al Dandan H. B.","year":"2022","journal-title":"Pilot and Feasibility Studies"},{"issue":"7","key":"e_1_2_11_127_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235961","article-title":"Medium\u2010Term Outcomes of Sacral Neuromodulation in Patients With Refractory Overactive Bladder: A Retrospective Single\u2010Institution Study","volume":"15","author":"Kaaki B.","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"e_1_2_11_128_1","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14040355","article-title":"Posterior Tibial Nerve Stimulation for the Treatment of Detrusor Overactivity in Multiple Sclerosis Patients: A Narrative Review","volume":"14","author":"Sapouna V.","year":"2024","journal-title":"Journal of Personalized Medicine"},{"issue":"8","key":"e_1_2_11_129_1","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/nau.24756","article-title":"Magnetic Resonance Imaging Interactions With a Sacral Neuromodulation System","volume":"40","author":"Huang X.","year":"2021","journal-title":"Neurourology and Urodynamics"},{"key":"e_1_2_11_130_1","doi-asserted-by":"crossref","DOI":"10.3389\/fruro.2026.1865760","article-title":"Efficacy and Safety of an Implantable Tibial Neuromodulation System for Overactive Bladder With Urgency Urinary Incontinence: An Open\u2010Label, Single Arm Trial","volume":"6","author":"Zheng F.","year":"2026","journal-title":"Frontiers in Urology"},{"issue":"3","key":"e_1_2_11_131_1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.urology.2012.11.010","article-title":"Long\u2010Term Efficacy and Safety of OnabotulinumtoxinA in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity: An Interim Analysis","volume":"81","author":"Kennelly M.","year":"2013","journal-title":"Urology"},{"issue":"5","key":"e_1_2_11_132_1","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13050359","article-title":"Novel Applications of Non\u2010Invasive Intravesical Botulinum Toxin A Delivery in the Treatment of Functional Bladder Disorders","volume":"13","author":"Jhang J. F.","year":"2021","journal-title":"Toxins"},{"issue":"4","key":"e_1_2_11_133_1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.7224\/1537-2073.2023-064","article-title":"Reasons for Hospital Admission in Individuals With Multiple Sclerosis","volume":"26","author":"Paredes D.","year":"2024","journal-title":"International Journal of MS Care"},{"key":"e_1_2_11_134_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102462","article-title":"Urinary Tract Infection in Patients With Multiple Sclerosis: An Overview","volume":"46","author":"Medeiros Junior W. L. G.","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"1","key":"e_1_2_11_135_1","first-page":"57","article-title":"Urinary Tract Infections in Multiple Sclerosis: Under\u2010Diagnosed and Under\u2010Treated? A Clinical Audit at a Large University Hospital","volume":"3","author":"Mahadeva A.","year":"2014","journal-title":"American Journal of Clinical and Experimental Immunology"},{"issue":"12","key":"e_1_2_11_136_1","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11121471","article-title":"The Clinical Trial Outcomes of Cranberry, D\u2010Mannose and NSAIDs in the Prevention or Management of Uncomplicated Urinary Tract Infections in Women: A Systematic Review","volume":"11","author":"Konesan J.","year":"2022","journal-title":"Pathogens"},{"key":"e_1_2_11_137_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013608"},{"issue":"6","key":"e_1_2_11_138_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11934-022-01094-w","article-title":"Non\u2010Antibiotic Approaches to Preventing Pediatric UTIs: A Role for D\u2010Mannose, Cranberry, and Probiotics?","volume":"23","author":"Ching C. B.","year":"2022","journal-title":"Current Urology Reports"},{"key":"e_1_2_11_139_1","article-title":"Efficacy and Safety of Intradetrusor AbobotulinumtoxinA and IncobotulinumtoxinA in Women With Overactive Bladder and the Value of Local Anesthesia: A Randomized Clinical Study","author":"Kavcic N.","year":"2024","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"6","key":"e_1_2_11_140_1","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the Treatment of Patients With Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial","volume":"189","author":"Nitti V. W.","year":"2013","journal-title":"Journal of Urology"},{"issue":"1","key":"e_1_2_11_141_1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/10538135251329322","article-title":"Spasticity Management With Botulinum Toxin in Post\u2010Stroke and Multiple Sclerosis Patients: A Retrospective, \u2018Real\u2010World\u2019, Multicenter Study","volume":"57","author":"Butera C.","year":"2025","journal-title":"Neurorehabilitation"},{"key":"e_1_2_11_142_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2024.107475","article-title":"The Use of IncobotulinumtoxinA in the Correction of Tremor in Multiple Sclerosis","volume":"237","author":"Peshkin A.","year":"2024","journal-title":"Toxicon"},{"key":"e_1_2_11_143_1","doi-asserted-by":"crossref","DOI":"10.3389\/fresc.2026.1838788","article-title":"Botulinum Toxin Treatment for Multiple Sclerosis and Post\u2010Stroke Spasticity in Clinical Practice: Differences in Injection Doses and Patterns","volume":"7","author":"Manganotti P.","year":"2026","journal-title":"Frontiers in Rehabilitation Sciences"},{"issue":"1","key":"e_1_2_11_144_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.11138\/FNeur\/2018.33.1.007","article-title":"Pharmacological Differences and Clinical Implications of Various Botulinum Toxin Preparations: A Critical Appraisal","volume":"33","author":"Ferrari A.","year":"2018","journal-title":"Functional Neurology"},{"issue":"2","key":"e_1_2_11_145_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.eururo.2022.03.010","article-title":"Efficacy and Safety of AbobotulinumtoxinA in Patients With Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results From Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2)","volume":"82","author":"Kennelly M.","year":"2022","journal-title":"European Urology"},{"issue":"3","key":"e_1_2_11_146_1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.juro.2016.03.146","article-title":"Durable Efficacy and Safety of Long\u2010Term OnabotulinumtoxinA Treatment in Patients With Overactive Bladder Syndrome: Final Results of a 3.5\u2010Year Study","volume":"196","author":"Nitti V. W.","year":"2016","journal-title":"Journal of Urology"},{"key":"e_1_2_11_147_1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2020.08.008","article-title":"Mirabegron Versus Solifenacin in Multiple Sclerosis Patients With Overactive Bladder Symptoms: A Prospective Comparative Nonrandomized Study","volume":"145","author":"Brucker B. M.","year":"2020","journal-title":"Urology"},{"issue":"2","key":"e_1_2_11_148_1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/nau.23887","article-title":"Bladder Management Experiences Among People Living With Neurologic Disease: A Systematic Review and Meta\u2010Synthesis of Qualitative Research","volume":"38","author":"Welk B.","year":"2019","journal-title":"Neurourology and Urodynamics"},{"key":"e_1_2_11_149_1","doi-asserted-by":"crossref","DOI":"10.1177\/20406223231172920","article-title":"Shared Decision\u2010Making in Multiple Sclerosis Physical Symptomatic Care: A Systematic Review","volume":"14","author":"Ben\u2010Zacharia A. B.","year":"2023","journal-title":"Therapeutic Advances in Chronic Disease"},{"key":"e_1_2_11_150_1","unstructured":"\u201cEuropean Association of Urology Guidelines \u201d presented at the EAU Annual Congress Paris 2024. ISBN 978\u201094\u201092671\u201023\u20103 (2024)."},{"key":"e_1_2_11_151_1","unstructured":"MS Society of Canada Bladder Dysfunction in MS(MS Society of Canada 2023) https:\/\/mscanadaca\/sites\/default\/files\/documents\/2023-03\/Bladder%20Dysfunction%20ENGpdf."},{"key":"e_1_2_11_152_1","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6193938","article-title":"A Descriptive Cross\u2010Sectional Study of Manipulative Dexterity on Different Subtypes of Multiple Sclerosis","volume":"2020","author":"Huertas\u2010Hoyas E.","year":"2020","journal-title":"Occupational Therapy International"},{"key":"e_1_2_11_153_1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ibneur.2026.07.018","article-title":"Oxidative Stress, Depressive Symptoms, Disability, Cognitive Outcomes and Hand Dexterity in Relapsing\u2010Remitting Multiple Sclerosis Patients With Mild\/Moderate Disability","volume":"21","author":"Mosaddeghi\u2010Heris R.","year":"2026","journal-title":"IBRO Neuroscience Reports"},{"key":"e_1_2_11_154_1","unstructured":"National Institute for Health and Care Excellence (NICE) Urinary Incontinence in Neurological Disease: Assessment and Management NICE Clinical Guidelines No. 148 (CG148) (NICE 2023)."},{"issue":"3","key":"e_1_2_11_155_1","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13030468","article-title":"Urine Biomarkers in the Management of Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review","volume":"13","author":"Koukourikis P.","year":"2023","journal-title":"Diagnostics"},{"issue":"6","key":"e_1_2_11_156_1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jtumed.2021.08.003","article-title":"Effects of Behavioural Therapy Versus Interferential Current on Bladder Dysfunction in Multiple Sclerosis Patients; a Randomised Clinical Study","volume":"16","author":"Al\u2010Shenqiti A. M.","year":"2021","journal-title":"Journal of Taibah University Medical Sciences"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.70492","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/nau.70492","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.70492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T07:03:55Z","timestamp":1792134235000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.70492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":155,"alternative-id":["10.1002\/nau.70492"],"URL":"https:\/\/doi.org\/10.1002\/nau.70492","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2026-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"nau.70492"}}